| 000 | 00921nam a2200265 4500 | ||
|---|---|---|---|
| 003 | KMLcat | ||
| 008 | 151116b xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9241546417 | ||
| 041 | _aEng | ||
| 082 |
_a616.89 _bIMP |
||
| 245 | _aImproving access and use of psychotropic medicines | ||
| 260 |
_c2005 _aGeneva _bWHO _g2005 |
||
| 300 |
_axi, 58, p. _bill. _c30 cm. |
||
| 440 |
_aMental health policy and service guidance package _96555 |
||
| 650 | _aMENTAL HEALTH | ||
| 655 |
_apsychotropic drugs-supply and distribution _911746 |
||
| 655 |
_adrug and narcotic control-methods _911747 |
||
| 655 |
_adrug costs _911748 |
||
| 655 |
_adrug utilization _910639 |
||
| 655 |
_aessential drugs-supply and distribution _911749 |
||
| 655 |
_aguidelines _94505 |
||
| 655 |
_amental disorders-drug therapy _911750 |
||
| 856 | _uhttp://www.who.int/mental_health/policy/services/essentialpackage1v10/en/ | ||
| 942 |
_s1 _cSPR _2ddc |
||
| 999 |
_c4466 _d4466 |
||